T. Rowe Price Associates
CHCT

T. Rowe Price Associates’s Community Healthcare Trust CHCT Stock Holding History

T. Rowe Price Associates’s Portfolio CHCT Stock Details CHCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
18,669
+2,217
+13% +$37.4K ﹤0.01% 2686
2025
Q4 		$271K Sell
16,452
-10,273
-38% -$153K ﹤0.01% 2693
2025
Q3 		$409K Buy
26,725
+4,740
+22% +$74.2K ﹤0.01% 2451
2025
Q2 		$366K Buy
21,985
+982
+5% +$16.2K ﹤0.01% 2448
2025
Q1 		$382K Buy
21,003
+1,067
+5% +$20.4K ﹤0.01% 2361
2024
Q4 		$383K Buy
19,936
+1,751
+10% +$31.7K ﹤0.01% 2398
2024
Q3 		$331K Buy
18,185
+745
+4% +$15.2K ﹤0.01% 2430
2024
Q2 		$408K Buy
17,440
+754
+5% +$18.3K ﹤0.01% 2273
2024
Q1 		$444K Buy
16,686
+919
+6% +$24.2K ﹤0.01% 2254
2023
Q4 		$421K Buy
15,767
+2,710
+21% +$74.6K ﹤0.01% 2251
2023
Q3 		$388K Buy
13,057
+538
+4% +$18.1K ﹤0.01% 2229
2023
Q2 		$414K Buy
12,519
+769
+7% +$26.7K ﹤0.01% 2220
2023
Q1 		$431K Buy
11,750
+302
+3% +$11.8K ﹤0.01% 2170
2022
Q4 		$410K Buy
11,448
+359
+3% +$12.2K ﹤0.01% 2226
2022
Q3 		$364K Sell
11,089
-1,045,969
-99% -$38.7M ﹤0.01% 2287
2022
Q2 		$38.3M Buy
1,057,058
+10,517
+1% +$394K ﹤0.01% 963
2022
Q1 		$44.2M Buy
1,046,541
+7,525
+0.7% +$326K ﹤0.01% 1008
2021
Q4 		$49.1M Buy
1,039,016
+65,361
+7% +$3M ﹤0.01% 1012
2021
Q3 		$44M Buy
973,655
+5,589
+0.6% +$271K ﹤0.01% 1065
2021
Q2 		$45.9M Buy
968,066
+112,448
+13% +$5.5M ﹤0.01% 1053
2021
Q1 		$39.5M Buy
855,618
+232,299
+37% +$10.8M ﹤0.01% 1086
2020
Q4 		$29.4M Buy
623,319
+88,283
+17% +$4.2M ﹤0.01% 1118
2020
Q3 		$25M Buy
535,036
+6,200
+1% +$284K ﹤0.01% 1089
2020
Q2 		$21.6M Buy
528,836
+40,058
+8% +$1.5M ﹤0.01% 1122
2020
Q1 		$18.7M Buy
488,778
+4,861
+1% +$211K ﹤0.01% 1098
2019
Q4 		$20.7M Buy
483,917
+2,269
+0.5% +$103K ﹤0.01% 1173
2019
Q3 		$21.5M Buy
481,648
+1,413
+0.3% +$59.5K ﹤0.01% 1129
2019
Q2 		$18.9M Buy
480,235
+88,938
+23% +$3.31M ﹤0.01% 1192
2019
Q1 		$14M Buy
+391,297
New +$13M ﹤0.01% 1261

Other funds holding CHCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's CHCT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Community Healthcare Trust (CHCT) stake by 13% in Q1 2026, buying an estimated $37.4K and bringing the position to 18,669 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

T. Rowe Price Associates first reported a position in CHCT in Q1 2019 and has held it in 29 quarters since. The position peaked at $49.1M in Q4 2021. 162 funds tracked by Wall St. Rank hold CHCT as of Q1 2026.

  • T. Rowe Price Associates held 18,669 shares of Community Healthcare Trust worth $297K as of Q1 2026.
  • T. Rowe Price Associates bought 2,217 Community Healthcare Trust shares in Q1 2026, an estimated $37.4K.
  • Community Healthcare Trust made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2686 holding.
  • T. Rowe Price Associates first reported a position in Community Healthcare Trust in Q1 2019 and has held it in 29 quarters since.
  • T. Rowe Price Associates's Community Healthcare Trust position peaked at $49.1M in Q4 2021.
  • 162 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.